Axl hFc Chimera[Biotin], Human
Axl HFc Chimera[Biotin], Human

Immobilized Human GAS6, His Tag at 2 μg/ml (100 μl/well) on the plate. Dose response curve for Axl hFc Chimera[Biotin], Human, hFc Tag with the EC50 of 8.5 ng/ml determined by ELISA.

Axl HFc Chimera[Biotin], Human

Immobilized Anti-Axl Antibody, hFc Tag at 0.5 μg/ml (100 μl/well) on the plate. Dose response curve for Axl hFc Chimera[Biotin], Human, hFc Tag with the EC50 of 26.8 ng/ml determined by ELISA.

Axl HFc Chimera[Biotin], Human

The purity of Axl hFc Chimera[Biotin], Human is greater than 95% as determined by SEC-HPLC.

Axl HFc Chimera[Biotin], Human

Axl hFc Chimera[Biotin], Human on Bis-Tris PAGE under reduced condition. The purity is greater than 95%.

Axl hFc Chimera[Biotin], Human

Axl, a member of the TAM (Tyro3, Axl, Mer) family, and its inhibitors can specifically break the kinase signaling nodes, allowing advanced patients to regain drug sensitivity with improved therapeutic efficacy. Overexpression and activation of Axl receptor tyrosine kinase have been widely accepted to promote cell proliferation, chemotherapy resistance, invasion, and metastasis in several human cancers, such as lung, breast, and pancreatic cancers.
Z04405
¥123,118.00

Ask us a question
Product Introduction
Species Human
Protein Construction
Axl (Ala26-Pro449)
Accession # P30530-1		 hFc
N-term C-term
Conjugate Biotin
Purity > 95% as determined by Bis­Tris PAGE 
Endotoxin Level Less than 1EU per μg by the LAL method.
Biological Activity Measured by its binding ability in a functional ELISA.Test result was comparable to standard batch.
Expression System HEK293
Theoretical Molecular Weight 72.6 kDa
Apparent Molecular Weight Due to glycosylation, the protein migrates to 80-110 kDa based on Bis-Tris PAGE result.
Formulation Lyophilized from 0.22μm filtered solution in PBS (pH 7.4).
Reconstitution Centrifuge the tube before opening. Reconstituting to a concentration more than 100 μg/ml is recommended. Dissolve the lyophilized protein in distilled water.
Storage & Stability Upon receiving, the product remains stable for 6 months at -20℃ or below. Upon reconstitution, the product should be stable for 3 months at -80℃. Avoid repeated freeze-thaw cycles.

Examples
  • Axl HFc Chimera[Biotin], Human
    • Axl HFc Chimera[Biotin], Human

    Immobilized Human GAS6, His Tag at 2 μg/ml (100 μl/well) on the plate. Dose response curve for Axl hFc Chimera[Biotin], Human, hFc Tag with the EC50 of 8.5 ng/ml determined by ELISA.

  • Axl HFc Chimera[Biotin], Human
    • Axl HFc Chimera[Biotin], Human

    Immobilized Anti-Axl Antibody, hFc Tag at 0.5 μg/ml (100 μl/well) on the plate. Dose response curve for Axl hFc Chimera[Biotin], Human, hFc Tag with the EC50 of 26.8 ng/ml determined by ELISA.

  • Axl HFc Chimera[Biotin], Human
    • Axl HFc Chimera[Biotin], Human

    The purity of Axl hFc Chimera[Biotin], Human is greater than 95% as determined by SEC-HPLC.

  • Axl HFc Chimera[Biotin], Human
    • Axl HFc Chimera[Biotin], Human

    Axl hFc Chimera[Biotin], Human on Bis-Tris PAGE under reduced condition. The purity is greater than 95%.


Background
Target Background Axl, a member of the TAM (Tyro3, Axl, Mer) family, and its inhibitors can specifically break the kinase signaling nodes, allowing advanced patients to regain drug sensitivity with improved therapeutic efficacy. Overexpression and activation of Axl receptor tyrosine kinase have been widely accepted to promote cell proliferation, chemotherapy resistance, invasion, and metastasis in several human cancers, such as lung, breast, and pancreatic cancers.
Synonyms Axl; UFO; AXL oncogene; AXL; ARK; JTK11; Tyro7; AI323647; EC 2.7.10; EC 2.7.10.1

For research use only. Not intended for human or animal clinical trials, therapeutic or diagnostic use.